Vildanat M 500SR Tab — Uses, Dosage & Benefits

Vildagliptin 50 mg + Metformin Hydrochloride 500 mg (Sustained Release)

Vildagliptin is a DPP-4 inhibitor that increases incretin levels (GLP-1/GIP), enhancing glucose-dependent insulin release and reducing glucagon. Metformin reduces hepatic glucose production and improves insulin sensitivity; the SR form provides prolonged action and may improve gastrointestinal tolerability.

Oral tablet. Usually taken once or twice daily as prescribed, preferably with meals to reduce stomach upset. Swallow whole; do not crush or chew sustained-release tablets. Regularly monitor blood glucose and follow diet/exercise advice.

Always follow your doctor's prescription. Do not self-medicate.